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Abstract
Radiation exposure to astronauts could be a significant obstacle for long duration manned space exploration
because of current uncertainties regarding the extent of biological effects. Furthermore, concepts for protective
shielding also pose a technically challenging issue due to the nature of cosmic radiation and current mass and
power constraints with modern exploration technology. The concern regarding exposure to cosmic radiation is
biological damage that is associated with increased oxidative stress. It is therefore important and would be
enabling to mitigate and/or prevent oxidative stress prior to the development of clinical symptoms and disease.
This paper hypothesizes a “systems biology” approach in which a combination of chemical and biological
mitigation techniques are used conjunctively. It proposes using new, therapeutic, medical gases as chemical
radioprotectors for radical scavenging and as biological signaling molecules for management of the body’s
response to exposure. From reviewing radiochemistry of water, biological effects of CO, H2, NO, and H2S gas, and
mechanisms of radiation biology, it can be concluded that this approach may have therapeutic potential for
radiation exposure. Furthermore, it also appears to have similar potential for curtailing the pathogenesis of other
diseases in which oxidative stress has been implicated including cardiovascular disease, cancer, chronic
inflammatory disease, hypertension, ischemia/reperfusion (IR) injury, acute respiratory distress syndrome, Parkinson’s
and Alzheimer’s disease, cataracts, and aging. We envision applying these therapies through inhalation of gas
mixtures or ingestion of water with dissolved gases.
Keywords: space radiation, radiolysis, radiochemistry, radiation shielding, therapeutic medical gas, reactive oxygen
species, oxidative stress, countermeasure
The Challenge of Space Radiation
Galactic Cosmic Rays (GCR), solar energetic particles
(SEP), and trapped energetic particles in a planetary
magnetic field are natural sources of radiation in space.
GCRs consist of highly energetic nuclei, predominately
protons and He, but also trace amounts of C, O, Ne, Si,
Ca, and Fe ions. Particle energies can range from 100
MeV to 10 GeV per nucleon [1]. Although the high
charge and energy (HZE) nuclei are in trace amounts,
they are still of concern because they can cause more
damage than protons since they are more highly
ionizing. As well, even though particle fluxes are typi-
cally low, they are chronic and can significantly increase
with solar events [1]. Furthermore, GCRs and SEPs
impinging on shielding material, atmosphere, or surface
of a planet or satellite can produce secondary radiation,
including energetic neutrons, from nuclear fragmenta-
tion of the primary ion and target atoms. This can
introduce an additional component to the radiation field
which makes shielding from HZE quite challenging and
poses one of the principal unknowns in understanding
the HZE effects with human tissue [2]. Furthermore,
while our bodies do possess a natural repair mechanism,
radiation with a high linear energy transfer (LET) rate,
like space radiation, is attributed to be more likely to
cause double strand breaks in DNA that are relatively
more difficult for our natural repair mechanisms to fix
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correctly [3]. While a week or month of this radiation at
the dose rates naturally present likely will not have ser-
ious consequences, several year durations in space
could. The traditional paradigm for radiation protection
is to minimize exposure time, maximize distance from
radiation sources, and use shielding to attenuate and
absorb radiation before it can deposit its energy in
humans. In regards to minimizing exposure time, new
propulsive technologies could reduce trip times but have
yet to be developed and would not address the ability to
remain at a location for long durations. It is impractical
to maximize distance from cosmic radiation sources. In
regards to shielding, aspects of attenuation by mass or
deflection by magnetic fields or charge repulsion have
been considered. Due to the phenomena of secondary
radiation, shielding by other matter may require a signif-
icant amount of mass which could be impractical within
current mass constraints in space systems. Due to the
high energy of the space radiation, magnetic field and
charge strengths required for deflection may be cur-
rently impractical because of mass and power con-
straints in modern space systems along with other
system design implications. In short, shielding space
radiation is seemingly quite challenging. However,
advances in biochemistry may reveal some more tools
for radiation protection [2].
Parallels between Radiation Chemistry
of Water & Radiobiology
Radiolysis is the decomposition of water from exposure
to ionizing radiation. Radiation chemistry of water has
been well studied since the onset of nuclear power pro-
duction, as water has been the most often used coolant.
Since mammalian cells are composed of about 80%
water, it seemed natural that there exist similarities
between radiation chemistry of water and radiation biol-
ogy. It is these similarities from which analogues for
radioprotective measures were inspired.
Chain of Events Initiated by Chemically Reactive Species
Radiolysis in nuclear systems causes a chain of events
that ultimately manifest into systematic problems like
corrosion and gas generation. Ionizing radiation creates
chemically reactive radicals H3O
+, e-, H+, H, and OH by
ionizing and/or breaking the bonds of water molecules.
These radicals then initiate a chain of chemical reactions
within the water which can result in the formation of
molecular decomposition products such as H2, O2, HO2
and H2O2. BWR recirculation water contains oxygen
and hydrogen peroxide in the concentration range from
100 to 300 ppb, and about 10 ppb of dissolved hydrogen
(less than stoichiometric ratio of 8 to 1) [4]. These oxi-
dizing species alter the water composition and therefore
its electrochemical character which facilitates the
manifestation of problems like corrosion or gas genera-
tion. As such, the nature in which systematic problems
develop can be viewed as stemming from a chain of
events that are initiated by ionization and propagated by
a scheme of chemical reactions with the net result or
outcome depending upon the ensuing chemistry.
This scenario is similar in nature to a biological sys-
tem and the pathogenesis of radiation related ailments
and disease. Ionization of key biological molecules can
lead to chemical reactions which transform these mole-
cules. This alters their biochemical function and can
result in changes of their biochemical properties. Modi-
fication of biochemical properties propagates from a cel-
lular level to organ and systematic changes that
ultimately manifest into clinical symptoms and ailments.
Ionization of the molecules can be initiated both directly
(by radiation) and indirectly (by free radicals and reac-
tive oxygen species (ROS) created by radiolysis). Free
radicals and ROS like O2
-, 1O2, ·OH, ·OOH, NO· and
H2O2 can cause cell injury or death by oxidative stress
[5,6]. Oxidative stress to the cell results from such
things as DNA damage or lipid peroxidation. Disease
can then develop as a direct result of radiation damage
or due to a system impairment caused by radiation
damage such as the case of radiation-induced damage of
chromosomes in lymphocytes compromising the
immune system’s ability to prevent tumor development
[7]. Overall, the greatest risks from radiation exposure
are assumed to be cancer [8], cataracts, and damage to
the central nervous system [9]. Thus the nature of the
problem seems similar to nuclear systems in that sys-
tematic manifestations result from a chain of events
initiated by ionization and propagated, in this case, by
ensuing chemical reactions and biological responses.
Interestingly enough, oxidative stress has been impli-
cated to play a role in the development of other diseases
as well [10,11]. That is, the normal production and
development of a variety of disorders and diseases has
also been associated with an increase of oxidative stress
and inflammation similar to that which would be caused
by exposure to radiation. For example, certain detrimen-
tal effects from space radiation on the dopaminergic sys-
tem are similar to functional changes that occur from
Parkinson’s disease [9], diabetogenic problems associated
with increased C-peptide excretion and insulin resis-
tance [12], as well as constipation due to malfunction of
the intestine. Oxidative stress during space flight can
cause a loss of protein after reductive remodeling of ske-
letal muscle due to undernutrition [13]. Diseases in
which oxidative stress is implicated, and thus which
could also be affected by the countermeasures proposed
in this paper, include cardiovascular disease, cancer [14],
chronic inflammatory disease [15], hypertension [16],
ischemia/reperfusion injury [5], acute respiratory distress
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syndrome (ARDS) [17], neurodegenerative diseases such
as Parkinson’s disease and Alzheimer’s disease [18,19]
and aging [20].
Radical Scavenging & Antioxidants
The actual chemical reactions that ensue and their by-
products depend upon what the radicals come into con-
tact with. For example, in pure water, radical-radical
interactions lead to the formation of the decomposition
products while radical-decomposition product reactions
lead to the reformation of water. In a nuclear system,
manifestation of system level problems has been cur-
tailed by interfering with the chain of events early on
during the chemical stages through the use of additives
that alter water composition. Whereas some additives
have been found to promote and increase water decom-
position, others have been found to suppress it [21].
This occurs through scavenging in which the additives
preferentially react with the radicals. Scavenging has the
effect of removing reactive species from the system and
thereby reduces their ability to participate in chemical
reactions that cause decomposition. While there are var-
ious additives that preferentially react with decomposi-
tion products, the byproducts of the scavenging reaction
are a factor as well since they are a component of the
water composition. For example, some ionic impurities
scavenge radicals (shown in 1-4) but do so at the
expense of water reformation as the consumed H and
OH radicals are no longer available to react with
decomposition products in the reactions that lead to
water reformation.
OH + Br− → Br + OH− (1)
H + Br → Br− + H+ (2)
H + Cu++ → Br− + H+ (3)
OH + Cu+ → Cu++ + OH− (4)
However, the use of excess H2 in a water system
exposed to radiation provides the initial H radicals for a
chain reaction that promotes water reformation and in
which there is no net consumption of H2 in the process
(shown in 5-6).
H2 + OH → H2O + H (5)
H + H2O2 → H2O + OH (6)
The ability of H2 to suppress total oxidant concentra-
tions in a water system exposed to radiation has long
been recognized by the boiling water reactor (BWR)
community and is referred to as hydrogen water
chemistry (HWC). The first full-scale HWC test in the
U.S. was performed at Dresden-2 in 1982 and similar
tests have subsequently been carried out in several reac-
tors [4]. In the presence of excess H2, both the water
decomposition and production of O2 can be suppressed
through a chain reaction which rapidly reduces the con-
centration of OH and H2O2. In an accelerator applica-
tion, Lillard et al. [22] has shown that this has the effect
of suppressing the Open Circuit Potential (OCP) of the
water (Figure 1) and thereby electrochemically reduces
the driving potential for corrosion.
Similarly, in a biological system, antioxidants have
been seen to protect against oxidative stress and pre-
vent the pathological process of a wide range of dis-
ease [23]. The effect of antioxidants in reducing
oxidative stress can be attributed to their ability to
protect tissues from free radicals [6] hinting towards a
scavenging mechanism. Turner [24] indicates, “A num-
ber of radiosensitizing chemicals and drugs are known.
Some sensitize hypoxic cells, but have little or no
effect on normally aerated cells. Other agents act as
radioprotectors reducing biological effectiveness...which
scavenge free radicals. Still other chemicals modifiers
have little effect on cell killing but substantially
enhance some multistep processes, such as oncogenic
cell transformation.” Thus it appears that antioxidants
act similarly to radical scavengers in nuclear coolant
systems in that they chemically protect against indirect
ionization by preferentially reacting with the reactive
species and thus reducing their ability to cause oxida-
tive stress.
The dependency of the outcome on scavenger type is
also similar to nuclear systems where the effect of the
type of additive can either be to promote water
Figure 1 The effect on OCP of the solution from H2 gas
bubbled into it and the addition of 0.1 M H2O2 as measured
by Tungsten/Tungsten-Oxide (ref. electrode) and Platinum
electrodes (vs. saturated calomel electrode SCE) [22].
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decomposition or water reformation. One such example
is the effect of oxygen. There appears to be parallels in
the effect of oxygen to promote water decomposition in
a nuclear system and increased radiosensitivity of cells
in the presence of oxygen as shown in Figure 2C[25].
With increased water decomposition, it would be
expected that there would be more ROS produced lead-
ing to increased damage. This is the case as cell survival
decreases under oxic conditions when exposed to X-
and g-rays implying that the indirect effect of radiolysis
byproducts are the most damaging to the cell. This oxy-
gen effect is quantified by the oxygen enhancement
ratio (OER) that reflects the relative increase of radia-
tion dose needed to produce the same biological damage
under hypoxic conditions as opposed to oxic conditions.
Figure 2D[25] includes the effect of hydrogen on water
decomposition and shows that when in excess of ROS
like O2 and H2O2, the water reformation process domi-
nates as ROS are quickly scavenged. This raises the
question of what would the effect of H2 be on radiosen-
sitivity of cells? Also noteworthy in Figure 2 is the
occurrence of an equilibrium where the amount of
molecular decomposition byproducts from radiolysis
remains constant. This hints at a scenario of two com-
peting processes in which a critical point occurs when a
balance is achieved between water decomposition and
reformation and suggests that radical scavengers can
shift which process dominates. Biological parallels and
implications of this are discussed next.
A Scenario of Competing Processes with a Critical Point &
Natural Repair Mechanisms
Radiolysis of water can be viewed as a scenario of com-
peting processes, water decomposition and reformation,
in which the outcome will depend upon where the pro-
cesses reach a balance or equilibrium. Decomposition
will still occur even in the presence of additives but they
serve to alter the net outcome by affecting the chemical
reactions such that one process becomes more dominat.
This was seen somewhat in Figure 2 and is shown more
explicitly in Figure 3[26] which shows that the equili-
brium point or threshold for which beyond negative
effects manifest can be increased through bolstering the
scavenging capacity and altering the balance such that
the favorable processes are dominant.
In a biological system, it appears to be a similar sce-
nario between biochemical damage and repair processes.
Free radicals and ROS were identified as the root cause
of oxidative stress and while their production is attribu-
ted to exposure to external sources like X-rays, ozone,
cigarette smoke, air pollutants and industrial chemicals
[27], they are also generated naturally during a variety
of energy-generating biochemical reactions and cellular
functions [5]. In fact, the ROS actually serve a necessary
Figure 2 (A)-(D)[25]reflect water decomposition by the concentration of radiolysis byproducts. (B) is an extension of (A) and is air free
pure water. Decomposition ensues until H2 in excess of ROS. (C) is effect of dissolved O2 in excess of H2 to promote decomposition. (D) is effect
of dissolved hydrogen in excess of O2 to scavenge. (E) [24] Shows effect of O2 as a biological radiosensitizer. N2 is also shown which raises the
question of what the effect of H2 would be.
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function as signaling molecules that critically modulate
the activation of the immune system and thus partici-
pate in antibacterial defense [28]. Thus, neutralization of
all free radicals would not be desirable. Oxidative stress
occurs when there is an imbalance between antioxidants
and ROS and free radicals [29] such as when ROS con-
centrations increase due to radiation exposure generat-
ing them by ionization. Chopping [3] observes, “The cell
is protected by different DNA repair mechanisms which
try to restore the damage. We don’t know the details,
except when the repair goes wrong (e.g. a replacement
of a lost nucleotide by a ‘wrong” base pair, etc.)... The
cell contains natural radical scavengers. As long as they
are in excess of the radiolysis products, the DNA may
be protected. When the products exceed the amount of
scavengers, radiation damage and cancer induction may
occur. In principle, there could thus be a threshold dose
for radiation damage, at which the free radicals formed
exceed the capacity of scavenging. The scavenging capa-
city may differ from individual to individual depending
on his/her physical condition.” Experimental investiga-
tions regarding long-duration space flights in particular
clearly showed increased oxidative stress markers and a
reduction in antioxidants after these flights [30,7]. Ken-
nedy et al. [31] demonstrated that exposure to space
radiation may compromise the capacity of the host anti-
oxidant defense system and that this adverse biological
effect can be prevented, at least partially, by dietary sup-
plementation with agents expected to have effects on
antioxidant activities. Interestingly and similarly so, the
radiation resistance of the bacteria Deinococcus radio-
durans that can grow under chronic g radiation (50 Gy/
hr) or recover from acute doses greater than 10 kGy has
been attributed to the role of antioxidants in mitigating
the extent of oxidative damage [32-34]. Thus there
appear to be similarities between the nuclear and biolo-
gical systems in how use of scavengers can enhance and
bolster the favorable process thereby increasing the nat-
ural radiation resistance of the system. Chopping [3]
points out that several radiation protection agents are
known and probably function as scavengers for the pro-
ducts of water radiolysis. However, the oxygen effect to
promote ROS production isn’t seen for the higher LET
a radiation where the OER is 1, as opposed to 3 as for
the case of X-rays, implying that direct damage such as
double strand DNA breaks becomes the more dominant
type of damage process for higher LET radiation. There-
fore, for the high LET space radiation, scavenging alone
may not be an effective mitigation approach. Thus, we
envision a strategy that interrupts the chain of events
leading to biological disease during the chemical and
biological stages. In particular, we propose a strategy
that (1) bolsters antioxidant capacity (2) supports nat-
ural repair processes and (3) manages biological
response to radiation insult. This approach could have a
great effect for increasing the threshold tolerance for
radiation damage before it propagates into systematic
symptoms, disease and ailments.
Radiation protection by a conjunctive
bio-chemical approach
Over the course of the last century, a wealth of knowl-
edge has been accumulated on the effect of radiation on
biological systems. Areas spanning in scope from DNA
damage up to changes in physiology have received
extensive study. To date, biology studies of radiation
damage have largely focused on components of DNA
repair systems such ataxia telangiectasia mutated gene
(ATM). More recently, however, it has been found that
modification of key molecular targets can protect tissue
from radiation induced fibrosis in mice exposed to
doses up to 25 Gy [35,36]. It has also been found that
changes in APOE (Apolipoprotein E) genotype dramati-
cally influences survival following Total Body Irradiation
(TBI) in murine models. These results imply that modi-
fication of key molecular targets to induce biological
changes in the host can protect tissue from radiation
damage. Turner [24] notes that, “for carcinogensis or
Figure 3 Relative contribution of the water decomposition
process is associated with boric acid concentration measured
in milli-molar on the abscissa. System scavenging capacity or
relative contribution of the water reformation process is associated
with the initial amount of dissolved H2 measured in micro-molar
concentrations (each curve). Manifestation of negative systematic
effects is reflected by the amount of water decomposition from
radiolysis as reflected by H2 gas generation rates measured in
micro-molar concentrations per minute on the ordinate. Figure
illustrates that the addition of dissolved H2 increases the scavenging
capacity of the water therefore increasing the threshold and
delaying the onset of when decomposition becomes the dominant
process [26].
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transformation, for example, such biological promoters
(radioprotectors) can dwarf the effects of physical fac-
tors, such as LET and dose rate, on dose-response
relationships.”
Radioprotectors have been implicated to work by the
following chemical and biological protective mechan-
isms:
1. radical scavenging of toxic decomposition pro-
ducts of free radicals and ROS
2. repair of biological molecules by donation of H
atoms since hydrogen bonds are among the weakest
in biological molecules and such are the first to be
broken [37]
3. interaction with cellular components (binding,
altering metabolic pathway, etc.)
Interaction with cellular components can have biolo-
gical effects that lend to radioprotection like hypoxia,
alteration of metabolic state, and anti-apoptotic and
anti-inflammatory properties. Tissue hypoxia decreases
the radiosensitivity of cells by minimizing the O2 effect
and can be produced chemically by impairing oxygen
transport (binding up hemogloblin with another mole-
cule) or biologically by either restricting blood flow
(vasoconstrictor drug, hypocapnia, etc.) or lowering
blood pressure (vasodilator drug). Vasodilation along
with other circulatory enhancements may also enhance
the natural repair mechanism as it is believed to be
more effective in a living organism, where the cells are
in continuous exchange with the surrounding cells and
body fluids, than in the tissue samples often studied in
the laboratory [3]. Inducing a hypometabolic state
which resembles hibernation, may contribute to toler-
ance against oxidative stress. Metabolic rates in hiber-
nating marmots and ground squirrels help delay the
onset of obvious damage. Also, survival times for gui-
nea pigs that have received massive doses of radiation
(> 6000 rads) have been extended from several hours
to about 4 days through the use of central nervous sys-
tem depressants (pentobarbital) where it has been
attributed to partial protection from central nervous
system syndrome [37]. Furthermore, a hypometabolic
status may also prove to be an ideal therapy for var-
ious shock or trauma states in which dramatic reduc-
tion in metabolic demands may be highly protective
[38]. Anti-apoptotic properties can mitigate organ
damage such as in IR injury by reducing the amount
of cellular self destruction. Interference with mitosis
and DNA synthesis may slow cells in their radio-resis-
tant phase of cell division or afford more time for nat-
ural repair of the cell prior to replication of the
damage.
We hypothesize that therapeutic medical gases can serve as
radioprotectors and biological signaling molecules to work
conjunctively in preventing, protecting, and repairing
radiation damage
Medical gases might prove to have lower chemical toxi-
city and thereby permit increased dose administration. If
so, this could improve effectiveness as many of the
radiation protective agents are limited to being adminis-
tered in small doses due to their chemical toxicity [3].
Furthermore, incorporating the biological aspect with
the chemical aspect of scavenging radiolysis byproducts
may prove to be particularly effective for space radiation
than using low LET radioprotectors as direct damage
such as DNA double strand breaks likely become the
more dominant damage mechanisms for the higher LET
radiation [3]. NO, CO, H2S and H2 are gaseous signaling
molecules in humans. These molecules act as transmit-
ters of information between cells by chemically interact-
ing with cell receptors to trigger a response within the
cell. These comprise some of the medical gases of inter-
est and many of them act both on the chemical level in
the form of antioxidant radical scavenging and on the
biological level in the form anti-inflammatory, anti-
apoptotic, and other biological effects. Extensive and
more detailed information about these gases in a thera-
peutic role can be found in reference [23] which pro-
vides a detailed description of medical gases of interest
and their properties and [39] provides detailed informa-
tion pertaining in particular to H2.
Hydrogen
We hypothesize that hydrogen can repair biological
radicals by H atom donation and/or supplement
antioxidant capacity either directly as an antioxidant or
indirectly as a signaling molecule to trigger production of
natural antioxidant enzymes
Hydrogen properties as a medical gas are summarized in
Table 1. Hydrogen may have potential as a safe and
potent therapeutic medical gas, as well as several poten-
tial advantages over current pharmacological therapies
for the following reasons:
• It is highly diffusible and as such may potentially
reach subcellular compartments, such as mitochon-
dria and nuclei, which are the primary site of ROS
generation and DNA damage [40] and are also
notoriously difficult to target pharmacologically.
• Its hyporeactivity with other gases at therapeutic
concentrations may allow hydrogen to be adminis-
tered with other therapeutic gases, including inhaled
anaesthesia agents [41].
• H2 may spare the innate immune system while still
allowing phagocytosis of infecting organisms. When
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tested in vitro, it did not eliminate O2
- or H2O2
which have important functions in neutrophils and
macrophages as they must generate ROS in order to
kill some types of bacteria engulfed by phagocytosis
[40]. It is not clear whether a similar reaction prefer-
entially occurs under complex biological conditions.
Experimental studies have demonstrated that hydro-
gen has potent therapeutic efficacies on both para-
site infection [42] and polymicrobial sepsis [43].
• No adverse effects have been found in humans
drinking hydrogen water in a study that examined
the effects of drinking hydrogen-rich water (HW) for
radiation-induced late adverse effects [44,45]. Studies
showed that the consumption of HW for 6 months
resulted in significant decrease of serum levels of
derivatives of Reactive Oxidative Metabolites
(dROMs) and an increase of biological antioxidant
power determined by Free Radical Analytical System
(FRAS). No severe adverse effects were seen during
follow up period. These results suggest that drinking
HW improved Quality of Life (QOL), associated
with decrease of oxidative injury markers, in patients
with radiotherapy.
Hydrogen has only recently been considered for thera-
peutic applications for radiation exposure [46,47] and
recent results are beginning to preliminarily demon-
strate its radioprotective effects in cultured cells and
rats when exposed to 4-8 Gy of g-irradiation from a Co-
60 source [48]. Qian, et al [48] found that a hydrogen
rich PBS treatment applied to human lymphocyte AHH-
1 cells increased cell vitality in that it decreased cellular
lactate dehydrogenase (LDH) leakage and attenuated
apoptosis. When the treatment was applied in vivo to
male BALB/c rats, they found it attenuated intestinal
injury, helped sustain levels of natural antioxidant
enzymes GSH & SOD, and reduced both lipid peroxida-
tion (as indicated by MDA) and oxidative stress (as
indicated by DNA base damage/lesion 8-OHdG). The
protective effects appear to be concentration dependent,
at least within the range of their test (up to 0.4 mmol/
L), and are more effective as a pre-treatment before
exposure rather than after. This may imply a protective
mechanism from an antioxidant role either by the
hydrogen itself or by it ‘signaling’ the production of nat-
ural anti-oxidant enzymes. While there appears to be
insignificant differences in levels of natural antioxidant
enzymes GSH & SOD from the treatment in this experi-
ment, other experiments have indicated hydrogen treat-
ment appears to increase antioxidant enzymes such as
catalase, SOD or heme oxygenase-1 [39,44]. None the
less, a protective effect seems apparent and questions of
how much hydrogen can be absorbed by ingestion, inha-
lation or injection and how long it will remain effective
along with other questions remain to be addressed.
Nitric Oxide
We hypothesize that NO and thrombospondin-1 signaling
might be used conjunctively to manage response to
radiation insult for tissue preservation
Medical properties for NO are summarized in Table 2
and effects are shown in Figure 4[49]. NO regulates pla-
telet activity, preservation of the normal structure of the
vessel wall and causes blood vessel dilation which may
increase tissue blood supply [23]. This could abate
inflammatory response and thus protect tissue from oxi-
dative injury. Results from NO studies that have exam-
ined the ability of patients to inhale NO to improve
outcome of acute respiratory distress syndrome (ARDS)
have had discrepant results from positive, negative or
neutral outcomes. Thus NO may be linked with both
protective and toxic effects depending upon concentra-
tions, source, timing of administration and the environ-
ment suggesting a narrow window for administration in
the treatment of oxidative injuries [50]. Reduction of
excessive and deleterious NO effects appear to be
Table 1 Cited Properties of H2 as a Medical Gas with Suggested Chemical/Biological Mechanisms.
Biochemical
Mechanism
Notes
radical scavenging
antioxidant
• selectively reduces hydroxyl radicals (•OH) and reactive nitrogen oxide species (NO2 and N2O3) but did not eliminate O2
-
or H2O2 when tested in in vitro [40].
• does not decrease the steady-state levels of nitric oxide (NO) [40] which may be beneficial as endogenous NO signaling
pathways modulate pulmonary vascular tone and leukocyte/endothelial interactions [64].
• increases antioxidant enzymes such as catalase, superoxide dismutase or heme oxygenase-1 [39,44].
• diminished lipid peroxidation as indicated by MDA levels when compared to air-treated grafts [65].
• drinking hydrogen-containing water with concentrations as low as 0.04 mM, significantly reduced the loss of
dopaminergic neurons, decreased accumulation of DNA damage, and lipid peroxidation in mice with Parkinson’s disease
induced by oral administration of MPTP [66].
anti-apoptotic • postulated to inhibit caspase-3 activation [67].
anti-inflammatory • down-regulation of pro-inflammatory cytokines, such as interleukin (IL)-1 b, IL-6, chemokine (CC motif) ligand 2 and
tumor necrosis factor-a (TNF-a) [68,69].
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controlled by blocking NO/cGMP signaling through
thrombospondin-1 signaling via its receptor CD47. This
has shown to both maintain the viability of normal tis-
sues against radiation induced fibrosis in murine models
following total body irradiation (25 Gy) and increase the
radiosensitivity of tumors [35,36,50].
Carbon Monoxide
We hypothesize that small, therapeutic concentrations of
CO and/or when used in conjunction with other medical
gases can decrease radiosensitivity without the deleterious
effects of excessive CO
Table 3 summarizes medical properties of CO gas. Fig-
ure 5 shows that administration of H2/CO mixtures has
been shown to reduce structural damage to hearts in
Lewis rats undergoing heart transplantation (HTx) in
which oxidative stress injury is caused by ischemia/
reperfusion [23] rather than radiation exposure. CO pro-
tects due to its capacity to bind hemoglobin and thereby
impair oxygen transport [37] which will reduce radio-
sensitization caused by the O2 effect to promote radical
production. However, when used solely, good protection
is obtained when an animal has 2/3 of its hemoglobin
bind in the form of carboxyhemoglobin. At this point
however, the animal is in a critical state [37] and
ischemic damage, metabolic acidosis and infections are
potentiated. While the adverse effects of inhaled CO are
a major concern for clinical use, experimental models
have demonstrated that potent therapeutic efficacies
exist at low concentrations [23,51]. Soluble forms of
Table 2 Cited Properties of NO as a Medical Gas with Suggested Chemical/Biological Mechanisms.
Biochemical
Mechanism
Notes
radical scavenging
antioxidant
• NO reacts with peroxy and oxy radicals generated during the process of lipid peroxidation. The reactions between NO
and these ROS can terminate lipid peroxidation and protect tissues from ROS-induced injuries [70].
• induces the rate-limiting antioxidant enzyme, heme oxygenase (HO)-1 thus imparting resistance to H2O2 induced cell
death [71].
• in bacteria, activates the redox-sentive transcriptional regulator protein (oxyR), resulting in the subsequent expression of
protein protective against ROS [72].
anti-inflammatory • inhibiting P-selectin expression and leukocyte recruitment [73].
decreased
radiosensitivity
• vasodilator through relaxation of vascular tone by stimulating soluble guanylate cyclase (sGC) and increased cGMP
content in vascular smooth muscle cells [23].
Figure 4 Images compare treated and untreated hind limbs 8 weeks after an exposure of 25 Gy showing that signs of fibrotic
contractures occurred only in the untreated limb[49].
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CO, such as CO-releasing molecules, may overcome the
problem of tissue hypoxia and allow clinical application
[52,53]. Recent animal studies have shown discrepant
results between exhibiting and not exhibiting anti-
inflammatory effects [23]. These discrepancies may be
attributed to species specific differences in the affinity of
CO for hemoglobin, or physiological differences such as
respiratory rate and sensitivity to lipopolysaccharides
(endotoxins) [54,55]. King and Lefer [56] point out,
“When tissue is subjected to ischaemia, the lack of oxy-
gen prevents mitochondrial respiration and oxidative
phosphorlyation, which leads to a rapid decline in ATP
concentration (Halestrap, 2010). Upon reperfusion, oxy-
gen and substrates are restored to the tissue and the
respiratory chain can restart, which leads to mitochon-
drial re-energization. This process allows mitochondria
to take up Ca2+ that has accumulated during ischaemia
(Halestrap, 2006). However, this restoration of oxygen
also causes a surge in free radicals produced by mito-
chondria. The combination of oxidative stress and high
matrix Ca2+ are ideal conditions for the induction of the
mitochondrial permeability of transition pore (MPTP).
The MPTP causes mitochondria to break down rather
than synthesize ATP and, if unrestrained, can lead to
cell death by way of necrosis.” However, they continued
in highlighting work from Elrod et al. [57] which indi-
cates that isolated mitochondria subjected to 30 min of
hypoxia, had a greater recovery of post-hypoxic respira-
tion rate when treated with Na2S. As well, treating at
reperfusion afforded a reduction in mitochondrial swel-
ling and an increase in matrix density suggesting preser-
vation of mitochondrial function [56]. This may suggest
that CO treatment may be enhanced when used in con-
junction with H2S or some sort of MPTP inhibitor like
ciclosporin A [56] in which King and Lefer referenced a
study by Shanmuganathan et al 2005.
Table 3 Cited Properties of CO as a Medical Gas with Suggested Chemical/Biological Mechanisms.
Biochemical
Mechanism
Notes
radical scavenging
antioxidant
• binds to the heme moiety of mitochondrial cytochrom c oxidase. By binding to the heme, CO may prevent degradation
of heme proteins which induce tissue injury by rapidly promoting peroxidation of the lipid membranes of cells [74,75].
• reduces mitochondria-derived ROS thus resulting in lower levels of ROS generation in which an adaptive cellular
response is triggered leading to cell survival rather than cell death [76-78].
• can induce HO-1 in cells to protect against injury [79-81]. Thus, detrimental excess of heme can be immediately
removed by HO-1 enzymatic activity induced by CO.
decrease radiosensitivity • impedes O2 transport as it binds to hemoglobin with an affinity 240 times higher than that of O2.
Figure 5 Extent of gross structural damage to heart graft was evaluated by TTC staining 3 hr after reperfusion. H2 and CO inhalation
reduced ischemic area following heart grafts but with only slight significance. Significant reduction is seen by dual treatment [23].
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Hydrogen Sulfide
We hypothesize that H2S administered in small, therapeutic
concentrations can enhance antioxidant activity and aid in
tissue preservation. Furthermore, it may support natural
DNA repair mechanisms by temporarily slowing cell cycle
progression so that more time is afforded to operate before
detrimental errors are copied
The medical properties of H2S are summarized in Table
4. H2S exerts a wide range of physiological roles in
mammalian tissue that contribute to cellular homeosta-
sis and protect the cell against oxidative stress, apopto-
sis, and necrosis [56]. It is produced enzymatically at
micromolar levels in mammals and is believed to help
regulate body temperature and metabolic activity at phy-
siological concentrations [58,59]. It has been implicated
as the mechanism by which consumption of garlic atte-
nuated cardiovascular disease where production of the
gas has been demonstrated to occur by bioconversion of
garlic-derived polysulfides by red blood cells [59].
Possible administration methods
Hydrogen or combinations of other medical gases could
be administered to astronauts by inhalation, ingestion or
injection. Inhalation could be achieved though a ventila-
tor circuit, facemask, nasal cannula, or creating a space-
suit or spacecraft atmosphere which is composed of or
contains a non-flammable gas mixture of these thera-
peutic medical gases. The use of Hydreliox, an exotic
breathing gas mixture of 49% hydrogen, 50% helium and
1% oxygen for prevention of decompression sickness
and nitrogen narcosis during very deep technical diving
[60], is one example of human inhalation of hydrogen
gas mixtures even though this particular mixture is sui-
ted only for deep technical diving applications. Drinking
hydrogen-rich water (HW) appears to have comparable
effects to hydrogen inhalation [61]. Although inhaled
hydrogen gas may act more rapidly, oral intake of
hydrogen-rich water is another method which may be
more practical for daily life or suitable for continuous
consumption in preventive or therapeutic uses. Ingestion
of gas dissolved solutions may prove to be more porta-
ble, easily administered, and a safe means of delivering
molecular hydrogen [62]. Gas rich water in which the
gases have been dissolved could be prepared by bub-
bling gases into solution under pressure or other disso-
lution methods like swept gas diffusion. However,
consideration will have to be given to loss of gas over
time by dissolution and diffusion. Alternatively, some
therapeutic gases such as hydrogen could be generated
in solution by chemical reaction with the solution such
as magnesium (Mg + 2H2O · Mg(OH)2 + H2). In this
case for example, a magnesium stick could be inserted
into the water just prior to drinking. However, consid-
eration will also have to be given to ingestion of the
produced byproducts as well. Though oral administra-
tion is safe and convenient, hydrogen can be lost from
solution by dissolution and diffusion and some hydrogen
is lost in the stomach or intestine, making it difficult to
control the concentration of hydrogen administrated.
Administration of hydrogen via an injectable hydrogen-
Table 4 Cited Properties of H2S as a Medical Gas with Suggested Chemical/Biological Mechanisms.
Biochemical
Mechanism
Notes
radical scavenging
antioxidant
• antioxidant inhibitor of peroxynitrite-mediated processes via activation of N-methly-D-aspartate (NMDA) receptors [82].
• shield cultured neurons from oxidative damage by increasing levels of glutathione [83].
• induce upregulation of HO-1, anti-inflammatory and cytoprotective genes [84,85].
• inhibits myeloperoxidase and destroys H2O2 [86].
• mediates mitochondrial preservation in post hypoxic conditions that are ideal for mitochondrial permeability transition
pore (MPTP) that would cause the mitochondria to break down and lead to cell death [56].
anti-apoptotic • reduces IR induced apoptosis via reduction of cleaved caspase-3 and cleaved poly (ADP-ribose) polymerase (PARP) [87].
• protection of isolated mitochondria by decreasing Ca2+ loading via vascular smooth muscle KATP channel-mediated
hyperpolarization [23,38,56] or inhibition of L-type Ca2+ channels.
• H2S activated STAT3 and Protein Kinase C (PKC) inhibits the pro-apoptotic factor Bad and upregulated the prosurvival
proteins Bcl-2 and Bcl-xl by altering phosphorylation [56].
• H2S influences inactivation of pro-apoptotic pathways through survival pathway of extracellular-signal regulated kinase
(ERK1/2)/mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI-3-kinase) [56].
anti-inflammatory • inhibit leukocyte adherence in the rat mesenteric microcirculation during vascular inflammation [38].
decrease radiosensitivity • transiently and reversibly inhibiting mitochondrial respiration [38].
metabolic alteration • produces a “suspended animation-like” metabolic status with hypothermia and reduced oxygen demand in pigs (who
received it intravenously) [88]. and mice (who received hydrogen sulfide via inhalation) [89,90].
• mice breathing 80 ppm of H2S for 6 hr reduced heart rate, core body temperature, respiratory rate and physical activity
where as blood pressure remained unchanged [56].
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rich solution may allow delivery of more accurate con-
centrations of hydrogen [63]. This method of adminis-
tration has been demonstrated for hydrogen in rats [48].
Conclusions
We hypothesize a systems approach of using various
therapeutic medical gases as chemical radioprotectors in
conjunction with biological signaling molecules to dis-
rupt the chain of events initiated by radiation exposure
and interfere with pathogenesis of disease. This could
have a profound positive effect as it addresses preven-
tion, protection, and repair. This represents a novel and
feasible preventative/therapeutic strategy to address
radiation-induced adverse events and thus the challenge
of space radiation. While more studies are warranted to
apply this therapy for space travel and determine details
of optimum gas mixtures and therapy administration
plans, it appears that it represents a potentially novel,
therapeutic, and preventative strategy that may also
ameliorate symptoms for other oxidative stress related
diseases as has been shown in relevant ground-based
(animal) models.
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